Lilly’s weight-loss drug expected to show heart benefit similar to Wegovy, experts say
Some leading obesity specialists in the US say they expect Eli Lilly’s potent weight-loss drug Zepbound to produce the same or similar cardiac benefits as Novo Nordisk’s popular Wegovy.
POPULAR POSTS
LIVE STREAM
